• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于 N-(2-羟丙基)甲基丙烯酰胺的线性、两嵌段和星型聚合物药物载体:其简单生产的先进工艺。

N-(2-Hydroxypropyl)methacrylamide-Based Linear, Diblock, and Starlike Polymer Drug Carriers: Advanced Process for Their Simple Production.

机构信息

Institut des Biomolécules Max Mousseron (IBMM - UMR 5247), CNRS, Université Montpellier , ENSCM, Faculté de Pharmacie , 15, Avenue Charles Flahault BP14491 , Montpellier Cedex 5 , France.

出版信息

Biomacromolecules. 2018 Oct 8;19(10):4003-4013. doi: 10.1021/acs.biomac.8b00973. Epub 2018 Sep 19.

DOI:10.1021/acs.biomac.8b00973
PMID:30180562
Abstract

We developed a new simplified method for the synthesis of well-defined linear, diblock, or starlike N-(2-hydroxypropyl)methacrylamide (HPMA)-based polymer drug carriers using controlled reversible addition-fragmentation chain transfer polymerization. The prepared monodispersed polymers are after the drug attachment intended for enhanced anticancer therapy. This new approach significantly reduces the number of required synthetic steps and minimizes the consumption of organic solvents during the synthesis. As a result, highly defined linear, diblock, and starlike copolymers designed for pH-triggered drug activation/release in tumor tissue were formed in sufficient amounts for further physicochemical and biological studies. Within the synthesis, we also developed a new procedure for the selective deprotection of tert-butoxycarbonyl hydrazide and amine groups on hydrophilic HPMA copolymers, including the one-pot removal of polymer end groups. We studied and described in detail the kinetics and efficacy of the deprotection reaction. We believe the simplified synthetic approach facilitates the preparation of polymer conjugates bound by the pH-sensitive hydrazone bond and their application in tumor treatment.

摘要

我们开发了一种新的简化方法,用于使用可控可逆加成-断裂链转移聚合合成具有明确结构的线性、二嵌段或星型 N-(2-羟丙基)甲基丙烯酰胺(HPMA)基聚合物药物载体。所制备的单分散聚合物在药物附着后,旨在增强抗癌治疗效果。这种新方法显著减少了所需的合成步骤的数量,并在合成过程中最小化了有机溶剂的消耗。结果,形成了大量数量的设计用于在肿瘤组织中 pH 触发药物激活/释放的高度明确的线性、二嵌段和星型共聚物,以便进行进一步的物理化学和生物学研究。在合成过程中,我们还开发了一种新的程序,用于选择性脱保护叔丁氧基羰基腙和亲水性 HPMA 共聚物上的胺基团,包括聚合物端基的一锅法去除。我们详细研究和描述了脱保护反应的动力学和效率。我们相信简化的合成方法促进了通过 pH 敏感腙键结合的聚合物缀合物的制备及其在肿瘤治疗中的应用。

相似文献

1
N-(2-Hydroxypropyl)methacrylamide-Based Linear, Diblock, and Starlike Polymer Drug Carriers: Advanced Process for Their Simple Production.基于 N-(2-羟丙基)甲基丙烯酰胺的线性、两嵌段和星型聚合物药物载体:其简单生产的先进工艺。
Biomacromolecules. 2018 Oct 8;19(10):4003-4013. doi: 10.1021/acs.biomac.8b00973. Epub 2018 Sep 19.
2
Tumor-targeted micelle-forming block copolymers for overcoming of multidrug resistance.用于克服多药耐药性的肿瘤靶向胶束形成嵌段共聚物。
J Control Release. 2017 Jan 10;245:41-51. doi: 10.1016/j.jconrel.2016.11.020. Epub 2016 Nov 18.
3
N-(2-Hydroxypropyl)methacrylamide-based polymer conjugates with pH-controlled activation of doxorubicin for cell-specific or passive tumour targeting. Synthesis by RAFT polymerisation and physicochemical characterisation.基于 N-(2-羟丙基)甲基丙烯酰胺的聚合物缀合物,具有 pH 控制的阿霉素激活作用,用于细胞特异性或被动肿瘤靶向。通过 RAFT 聚合合成和物理化学表征。
Eur J Pharm Sci. 2010 Nov 20;41(3-4):473-82. doi: 10.1016/j.ejps.2010.08.003. Epub 2010 Aug 7.
4
HPMA copolymer conjugates with reduced anti-CD20 antibody for cell-specific drug targeting. I. Synthesis and in vitro evaluation of binding efficacy and cytostatic activity.用于细胞特异性药物靶向的抗CD20抗体减少的HPMA共聚物缀合物。I. 结合效力和细胞生长抑制活性的合成及体外评估。
J Control Release. 2009 Nov 16;140(1):18-26. doi: 10.1016/j.jconrel.2009.07.011. Epub 2009 Jul 24.
5
Polymer conjugates of doxorubicin bound through an amide and hydrazone bond: Impact of the carrier structure onto synergistic action in the treatment of solid tumours.阿霉素通过酰胺键和腙键结合的聚合物缀合物:载体结构对治疗实体瘤协同作用的影响。
Eur J Pharm Sci. 2014 Jul 16;58:1-12. doi: 10.1016/j.ejps.2014.02.016. Epub 2014 Mar 13.
6
Bloodstream Stability Predetermines the Antitumor Efficacy of Micellar Polymer-Doxorubicin Drug Conjugates with pH-Triggered Drug Release.血流稳定性决定了具有 pH 触发药物释放的胶束聚合物-阿霉素药物偶联物的抗肿瘤疗效。
Mol Pharm. 2018 Sep 4;15(9):3654-3663. doi: 10.1021/acs.molpharmaceut.8b00156. Epub 2018 Mar 21.
7
Pronounced Cellular Uptake of Pirarubicin versus That of Other Anthracyclines: Comparison of HPMA Copolymer Conjugates of Pirarubicin and Doxorubicin.吡柔比星与其他蒽环类药物相比有明显的细胞摄取:吡柔比星和多柔比星的HPMA共聚物缀合物的比较。
Mol Pharm. 2016 Dec 5;13(12):4106-4115. doi: 10.1021/acs.molpharmaceut.6b00697. Epub 2016 Nov 21.
8
Backbone degradable multiblock N-(2-hydroxypropyl)methacrylamide copolymer conjugates via reversible addition-fragmentation chain transfer polymerization and thiol-ene coupling reaction.通过可逆加成-断裂链转移聚合和硫醇-烯点击反应制备可降解多嵌段 N-(2-羟丙基)甲基丙烯酰胺共聚物偶联物。
Biomacromolecules. 2011 Jan 10;12(1):247-52. doi: 10.1021/bm101254e. Epub 2010 Dec 15.
9
Highly effective anti-tumor nanomedicines based on HPMA copolymer conjugates with pirarubicin prepared by controlled RAFT polymerization.基于 HPMA 共聚物与吡柔比星偶联物的高效抗肿瘤纳米药物,通过可控 RAFT 聚合制备。
Acta Biomater. 2020 Apr 1;106:256-266. doi: 10.1016/j.actbio.2020.02.011. Epub 2020 Feb 11.
10
Self-association properties of HPMA copolymers containing an amphipathic heptapeptide.含有两亲性七肽的HPMA共聚物的自缔合性质
J Drug Target. 2007 Aug-Sep;15(7-8):465-74. doi: 10.1080/10611860701500016.

引用本文的文献

1
Branched glycopolymer prodrug-derived nanoassembly combined with a STING agonist activates an immuno-supportive status to boost anti-PD-L1 antibody therapy.与STING激动剂联合的支链糖聚合物前药衍生纳米组装体激活免疫支持状态以增强抗PD-L1抗体治疗。
Acta Pharm Sin B. 2024 May;14(5):2194-2209. doi: 10.1016/j.apsb.2024.02.006. Epub 2024 Mar 2.
2
Polymer theranostics with multiple stimuli-based activation of photodynamic therapy and tumor imaging.基于多种刺激的光动力治疗和肿瘤成像的聚合物治疗诊断一体化。
Theranostics. 2023 Sep 4;13(14):4952-4973. doi: 10.7150/thno.86211. eCollection 2023.
3
Singlet Oxygen : It Is All about Intensity-Part 2.
单线态氧:一切都与强度有关 - 第2部分。
J Pers Med. 2023 Apr 30;13(5):781. doi: 10.3390/jpm13050781.
4
Evaluation of linear versus star-like polymer anti-cancer nanomedicines in mouse models.线性聚合物与星形聚合物抗癌纳米药物在小鼠模型中的评价。
J Control Release. 2023 Jan;353:549-562. doi: 10.1016/j.jconrel.2022.11.060. Epub 2022 Dec 10.
5
Dual Functionalization of Gelatin for Orthogonal and Dynamic Hydrogel Cross-Linking.明胶的双重功能化用于正交和动态水凝胶交联。
ACS Biomater Sci Eng. 2021 Sep 13;7(9):4196-4208. doi: 10.1021/acsbiomaterials.1c00709. Epub 2021 Aug 9.
6
HPMA Copolymer-Based Nanomedicines in Controlled Drug Delivery.基于聚甲基丙烯酸羟乙酯共聚物的纳米药物用于可控药物递送
J Pers Med. 2021 Feb 10;11(2):115. doi: 10.3390/jpm11020115.
7
HPMA-Based Copolymers Carrying STAT3 Inhibitor Cucurbitacin-D as Stimulus-Sensitive Nanomedicines for Oncotherapy.基于HPMA的共聚物负载信号转导和转录激活因子3(STAT3)抑制剂葫芦素-D作为用于肿瘤治疗的刺激敏感型纳米药物
Pharmaceutics. 2021 Jan 28;13(2):179. doi: 10.3390/pharmaceutics13020179.
8
Structure-to-Efficacy Relationship of HPMA-Based Nanomedicines: The Tumor Spheroid Penetration Study.基于HPMA的纳米药物的构效关系:肿瘤球体渗透研究。
Pharmaceutics. 2020 Dec 20;12(12):1242. doi: 10.3390/pharmaceutics12121242.
9
Polymer nanomedicines.聚合物纳米药物。
Adv Drug Deliv Rev. 2020;156:40-64. doi: 10.1016/j.addr.2020.07.020. Epub 2020 Jul 28.
10
Polymer Nanomedicines with Ph-Sensitive Release of Dexamethasone for the Localized Treatment of Inflammation.用于炎症局部治疗的具有pH敏感地塞米松释放功能的聚合物纳米药物
Pharmaceutics. 2020 Jul 25;12(8):700. doi: 10.3390/pharmaceutics12080700.